MRI with Gadolinium-Based Nanoparticles - Nanotechnology for Biomedical Imaging and Diagnostics - page 253

on gadonanotube-reinforced biodegradable polymer nanocomposites. J Biomed Mater
Res A 2010; 93a :1454-1462.
[159] Hainfeld JF, dilmanian FA, slatkin dn, smilowitz HM. Radiotherapy enhancement
with gold nanoparticles. J pharm pharmacol 2008; 60 :977-985.
[160] debouttière pJ, Roux s, Vocanson F, Billotey C, Beuf O, Favre-Réguillon A, Lin Y,
pellet-Rostaing s, Lamartine R, perriat p. design of gold nanoparticles for magnetic
resonance imaging. Adv Funct Mater 2006; 16 :2330-2339.
[161] park J-A, Reddy pAn, Kim H-K, Kim I-s, Kim G-C, Chang Y, Kim T-J. Gold nanopar-
ticles functionalised by Gd-complex of dTpA-bis(amide) conjugate of glutathione as an
MRI contrast agent. Bioorg Med Chem Lett 2008; 18 :6135-6137.
[162] Alric C, Taleb J, duc GL, Mandon C, Billotey C, Meur-Herland AL, Brochard T,
Vocanson F, Janier M, perriat p, Roux s, Tillement O. Gadolinium chelate coated gold
nanoparticles as contrast agents for both x-ray computed tomography and magnetic
resonance imaging. J Am Chem soc 2008; 130 :5908-5915.
[163] Warsi MF, Chechik V. strategies for increasing relaxivity of gold nanoparticle based
MRI contrast agents. phys Chem Chem phys 2011; 13 :9812-9817.
[164] Lim YT, Cho MY, Choi Bs, Lee JM, Chung BH. paramagnetic gold nanostructures for
dual modal bioimaging and phototherapy of cancer cells. Chem Commun (Camb)
2008; 40 :4930-4932.
[165] Warsi MF, Adams RW, duckett sB, Chechik V. Gd-functionalised Au nanoparticles as
targeted contrast agents in MRI: relaxivity enhancement by polyelectrolyte coating.
Chem Commun (Camb) 2010; 46 :451-453.
[166] song Y, Xu X, MacRenaris KW, Zhang X-Q, Mirkin CA, Meade TJ. Multimodal gado-
linium-enriched dnA-gold nanoparticle conjugates for cellular imaging. Angew Chem
Int ed engl 2009; 48 :9143-9147.
[167] douglas T, Young M. Host-guest encapsulation of materials by assembled virus protein
cages. nature 1998; 393 :152-155.
[168] pokorski JK, steinmetz nF. The art of engineering viral nanoparticles. Mol pharm
2010; 8 :29-43.
[169] Allen M, Bulte JWM, Liepold L, Basu G, Zywicke HA, Frank JA, Young M, douglas
T. paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance
contrast agents. Magn Reson Med 2005; 54 :807-812.
[170] Anderson eA, Isaacman s, peabody ds, Wang eY, Canary JW, Kirshenbaum K. Viral
nanoparticles donning a paramagnetic coat: conjugation of MRI contrast agents to the
Ms2 capsid. nano Lett 2006; 6 :1160-1164.
[171] prasuhn Jde, Yeh RM, Obenaus A, Manchester M, Finn MG. Viral MRI contrast
agents: coordination of Gd by native virions and attachment of Gd complexes by azide-
alkyne cycloaddition. Chem Commun (Camb) 2007; 12 :1269-1271.
[172] Hooker JM, datta A, Botta M, Raymond Kn, Francis MB. Magnetic resonance contrast
agents from viral capsid shells: a comparison of exterior and interior cargo strategies.
nano Lett 2007; 7 :2207-2210.
[173] Garimella pd, datta A, Romanini dW, Raymond Kn, Francis MB. Multivalent, high-
relaxivity MRI contrast agents using rigid cysteine-reactive gadolinium complexes.
J Am Chem soc 2011; 133 :14704-14709.
[174] engström M, Klasson A, pedersen H, Vahlberg C, Käll p-O, uvdal K. High proton relax-
ivity for gadolinium oxide nanoparticles. Magn Reson Mater phy 2006; 19 :180-186.